Abstract:Clinical significance of combined detection of CCL22 and IL‐1 as potential new bronchial inflammatory mediators in children asthma. Backgrounds Severe asthma is a significant health burden because children with severe asthma are vulnerable to medication‐related side effects, life‐threatening deterioration, and impaired quality of life. However, there is a lack of data to elucidate the role of inflammatory variables in asthma. This study aimed to compare the levels of inflammatory factors in serum and sputum in children with acute and stable asthma to those in healthy children and the ability to predict clinical response to azithromycin therapy. Methods This study recruited 95 individuals aged 1−3 years old and collected data from January 2018 to 2020. We examined serum and sputum inflammatory factors and constructed the least absolute shrinkage and selection operator (LASSO) model. Predictive models were constructed through multifactor logistic regression and presented in the form of column‐line plots. The performance of the column‐line diagrams was measured by subject work characteristics (ROC) curves, calibration plots, and decision curve analysis (DCA). Then, filter‐paper samples were collected from 45 children with acute asthma who were randomly assigned to receive either azithromycin (10 mg/kg, n = 22) or placebo (n = 23). Pretreatment levels of immune mediators were then analyzed and compared with clinical response to azithromycin therapy. Results Of the 95 eligible participants, 21 (22.11%) were healthy controls, 29 (30.53%) had stable asthma, and 45 (47.37%) had acute asthma. The levels of interferon‐γ (IFN‐γ), tumor necrosis factor‐a (TNF‐α), chemokine CCL22 (CCL22), interleukin 12 (IL‐12), chemokine CCL4 (CCL4), chemokine CCL2 (CCL2), and chemokine CCL13 (CCL13)were significantly higher in the acute asthma group than in the stable asthma group. A logistic regression analysis was performed using CCL22 and IL‐1 as independent variables. Additionally, IFN‐γ, TNF‐α, IL‐1, IL‐13, and CCL22 were identified in the LASSO model. Finally, we found that CCL22 and IL‐1 were more responsive in predicting the response to azithromycin treatment. Conclusion Our results show that CCL22 and IL‐1 are both representative markers during asthma symptom exacerbations and an immune mediator that can predict response to azithromycin therapy.

Peripheral Pathological ILC2: an Inflammatory Indicator for the Assessment of Asthma Control in Clinics

Pathological ILC2 in Peripheral Blood Acts As an Indicator for the Assessment of Asthma Control in Clinics

IL-13+ Type 2 Innate Lymphoid Cells Correlate with Asthma Control Status and Treatment Response.

[Determination of Th1/Th2 Cytokines and Chemokines in Patients with Allergic Diseases and Its Significance].

Innate-like Lymphocytes and Innate Lymphoid Cells in Asthma

Interleukin-31 Expression and Relation to Disease Severity in Human Asthma.

Increased Expression of Type 2 Innate Lymphoid Cells in Pediatric Patients with Allergic Rhinitis.

Clinical Significance of Combined Detection of CCL22 and IL‐1 as Potential New Bronchial Inflammatory Mediators in Children's Asthma

T-helper cells and their cytokines in pathogenesis and treatment of asthma

Interleukin-2 family cytokines IL-9 and IL-21 differentially regulate innate and adaptive type 2 immunity in asthma

The roles of thymic stromal lymphopoietin receptor and its antibody in airway inflammatory response in asthmatic mice

Exploration of plasma interleukin-27 levels in asthma patients and the correlation with lung function

ILC2s Induce Adaptive Th2-Type Immunity in Acute Exacerbation of Chronic Obstructive Pulmonary Disease

The absence of IL-9 reduces allergic airway inflammation by reducing ILC2, Th2 and mast cells in murine model of asthma

IRF3 Promotes Asthma Pathogenesis by Regulating Type 2 Innate Lymphoid Cells

Modulating ILC2 function for treatment of type 2 airway diseases

Inflammatory parameters and innate lymphoid cells in chilhood interstitial lung diseases: a prospective study

[Cytokine Profiles of CD4(+) T Memory Cells in Asthma and Their Relationship with Asthma Severity].

Reduced CCR6+IL-17A+Treg Cells in Blood and CCR6-Dependent Accumulation of IL-17A+Treg Cells in Lungs of Patients With Allergic Asthma

Elevated Proportions of Circulating CXCR5 + Follicular Helper T Cells Reflect the Presence of Airway Obstruction in Asthma

Regulatory T Cells and Th1/Th2 in Peripheral Blood and Their Roles in Asthmatic Children.